Atlas Venture

Funding rounds backed by Atlas Venture.

Export CSV
Funding disclosed in full
$168M
Median round
$84M
Rounds in calculation
2
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Triveni Bio

Develops novel antibody treatments for immunological and inflammatory disorders

$65MSeries CBiotechUnited States
7 participantsAlexandria VentureAscenta CapitalAtlas VentureDeep Track CapitalFidelityGoldman SachsJanus Henderson Investors
Kinaset Therapeutics

Develops inhaled therapies for severe respiratory diseases

$103MSeries BBiotechUnited States
11 participants5AM VenturesAtlas VentureEQT Life SciencesForge Life Science PartnersGimvPictet Alternative AdvisorsRA Capital ManagementSchroders CapitalSixty Degree CapitalVivo CapitalWillett Advisors